-
Signature
-
/s/ Michael Schultz, Attorney-in-Fact for Daniel De Lorenzo
-
Stock symbol
-
NTAP
-
Transactions as of
-
Nov 15, 2024
-
Transactions value $
-
-$58,563
-
Form type
-
4
-
Date filed
-
11/19/2024, 06:13 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NTAP |
Common Shares |
Options Exercise |
|
+499 |
|
|
499 |
Nov 15, 2024 |
Direct |
F1 |
transaction |
NTAP |
Common Shares |
Tax liability |
-$20.3K |
-173 |
-34.67% |
$117.21 |
326 |
Nov 15, 2024 |
Direct |
|
transaction |
NTAP |
Common Shares |
Sale |
-$38.3K |
-326 |
-100% |
$117.44 |
0 |
Nov 18, 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NTAP |
Restricted Stock Unit |
Options Exercise |
|
-175 |
-33.33% |
|
350 |
Nov 15, 2024 |
Common Shares |
175 |
|
Direct |
F1, F3 |
transaction |
NTAP |
Restricted Stock Unit |
Options Exercise |
|
-70 |
-20.11% |
|
278 |
Nov 15, 2024 |
Common Shares |
70 |
|
Direct |
F1, F4 |
transaction |
NTAP |
Restricted Stock Unit |
Options Exercise |
|
-108 |
-14.34% |
|
645 |
Nov 15, 2024 |
Common Shares |
108 |
|
Direct |
F1, F5 |
transaction |
NTAP |
Restricted Stock Unit |
Options Exercise |
|
-146 |
-9.07% |
|
1.46K |
Nov 15, 2024 |
Common Shares |
146 |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: